Skip to content

Insider · CIK 0001864430

Lauren White

cfoofficer

Files at IMGN (ImmunoGen, Inc.), SPTX (Seaport Therapeutics, Inc.). First filing -, latest -.

In brief

Lauren White files SEC Form 4 as CFO at IMGN (ImmunoGen, Inc.), and also at SPTX (Seaport Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Lauren White has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 7 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 4, 2026SPTX
Seaport Therapeutics, Inc.
CConversion
Common Stockindirect: By Lauren Anne White Living Trust, dated January 30, 2020
+6,702--6,702May 4, 2026
Apr 30, 2026SPTX
Seaport Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+63,680$0.00$063,680May 4, 2026
May 4, 2026SPTX
Seaport Therapeutics, Inc.
CConversion
Series B Preferred Stockderivativeindirect: By Lauren Anne White Living Trust, dated January 30, 2020
-21,052$0.00$00May 4, 2026
Feb 12, 2024IMGN
ImmunoGen, Inc.
DDisposition to issuer
Stock Option (Right to Buy)derivative
+295,975--0Feb 12, 2024
Feb 12, 2024IMGN
ImmunoGen, Inc.
DDisposition to issuer
Restricted Stock Unitderivative
+51,625--0Feb 12, 2024
Feb 12, 2024IMGN
ImmunoGen, Inc.
DDisposition to issuer
Restricted Stock Unitderivative
+19,519--0Feb 12, 2024
Feb 1, 2024IMGN
ImmunoGen, Inc.
AGrant or award
Restricted Stock Unitderivative
+19,519$0.00$019,519Feb 5, 2024

Questions about Lauren White

Answered from the filings on this page, as of the latest one.

Is Lauren White buying or selling?

Lauren White has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Lauren White's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lauren White has 0.

Where does Lauren White file Form 4?

Lauren White has filed Form 4 at IMGN (ImmunoGen, Inc.) as SVP, CFO AND PFO; SPTX (Seaport Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Lauren White: insider trades and track record | InsiderTell